Schonfeld Strategic Advisors’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-27,300
| Closed | -$36K | – | 2824 |
|
|
2022
Q3 | $36K | Sell |
27,300
-31,800
| -54% | -$41.9K | ﹤0.01% | 2612 |
|
|
2022
Q2 | $131K | Buy |
59,100
+39,200
| +197% | +$86.9K | ﹤0.01% | 1988 |
|
|
2022
Q1 | $123K | Buy |
+19,900
| New | +$123K | ﹤0.01% | 2105 |
|
|
2021
Q3 | – | Sell |
-7,800
| Closed | -$413K | – | 2250 |
|
|
2021
Q2 | $413K | Buy |
+7,800
| New | +$413K | ﹤0.01% | 1243 |
|
|
2020
Q4 | – | Sell |
-27,937
| Closed | -$1.4M | – | 1771 |
|
|
2020
Q3 | $1.4M | Buy |
27,937
+14,292
| +105% | +$715K | 0.03% | 579 |
|
|
2020
Q2 | $631K | Buy |
+13,645
| New | +$631K | 0.02% | 689 |
|
|
2019
Q3 | – | Sell |
-11,500
| Closed | -$489K | – | 1181 |
|
|
2019
Q2 | $489K | Buy |
+11,500
| New | +$489K | 0.02% | 635 |
|